137 related articles for article (PubMed ID: 761607)
1. Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma.
Sim RB; Reboul A; Arlaud GJ; Villiers CL; Colomb MG
FEBS Lett; 1979 Jan; 97(1):111-5. PubMed ID: 761607
[No Abstract] [Full Text] [Related]
2. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
Sim RB; Arlaud GJ; Colomb MG
Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
[No Abstract] [Full Text] [Related]
3. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
Cooper NR; Ziccardi RJ
J Immunol; 1977 Nov; 119(5):1664-7. PubMed ID: 915274
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
Bauer J; Valet G
Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
[TBL] [Abstract][Full Text] [Related]
5. Preparation and properties of human C1 inhibitor.
Sim RB; Reboul A
Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
[No Abstract] [Full Text] [Related]
6. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
Bianchino AC; Poon PH; Schumaker VN
J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
[TBL] [Abstract][Full Text] [Related]
7. Structural features of the first component of human complement, C1, as revealed by surface iodination.
Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
Jackson J; Sim RB; Whaley K; Feighery C
J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
[TBL] [Abstract][Full Text] [Related]
9. Purification of subcomponents Clq, Cl(-)r and Cl(-)s of the first component of complement from Cohn Fraction I by affinity chromatography.
Bing DH; Andrews JM; Morris KM; Cole E; Irish V
Prep Biochem; 1980; 10(3):269-96. PubMed ID: 6251443
[No Abstract] [Full Text] [Related]
10. Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.
Arlaud GJ; Villiers CL; Chesne S; Colomb MG
Biochim Biophys Acta; 1980 Nov; 616(1):116-29. PubMed ID: 6254570
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.
Woo P; Lachmann PJ; Harrison RA; Amos N; Cooper C; Rosen FS
Clin Exp Immunol; 1985 Jul; 61(1):1-8. PubMed ID: 4042415
[TBL] [Abstract][Full Text] [Related]
12. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
Aubert B; Chesne S; Arlaud GJ; Colomb MG
Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
Nilsson T; Wiman B
Eur J Biochem; 1983 Jan; 129(3):663-7. PubMed ID: 6297891
[No Abstract] [Full Text] [Related]
14. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
15. Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin.
Erdei A; Reid KB
Biochem J; 1988 Oct; 255(2):493-9. PubMed ID: 3144267
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical data on C1 intrinsic activation (author's transl)].
Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
[TBL] [Abstract][Full Text] [Related]
17. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
Tenner AJ; Frank MM
J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
[TBL] [Abstract][Full Text] [Related]
18. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
Fujii S; Hitomi Y
Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in breast cancer patients.
Croce MV; Pasqualini RS; Segal-Eiras A
Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
[No Abstract] [Full Text] [Related]
20. Interaction of C1q with beta 2-microglobulin.
Björck L; Johnson U; Sjöholm AG
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
